Cybin (HELP) Stock Analysis
NASDAQHealthcareMedical - Pharmaceuticals
What Cybin does
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Key metrics
ETFs linked to HELP
Broad-market and Healthcare sector ETFs an investor holding Cybin is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how HELP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze HELP in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Cybin?
- Cybin trades under the ticker HELP on NASDAQ.
- Which exchange is HELP listed on?
- HELP is listed on NASDAQ.
- What sector does Cybin operate in?
- Cybin is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
- How can PortView help analyze HELP in a portfolio?
- PortView shows HELP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.